1-(2-(BENZO[D]THIAZOL-2-YL)PROPAN-2-YL)-3-PHENYL-1H-PYRROL-2(5H)-ONE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	AMUZSLDZCOGPDB-UHFFFAOYSA-N
Smiles	CC(C)(N1CC=C(C1=O)c2ccccc2)c3nc4ccccc4s3
InChI	InChI=1S/C20H18N2OS/c1-20(2,19-21-16-10-6-7-11-17(16)24-19)22-13-12-15(18(22)23)14-8-4-3-5-9-14/h3-12H,13H2,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C20H18N2OS
Molecular Weight	334.43
AlogP	4.08
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	3.0
Polar Surface Area	61.44
Molecular species	NEUTRAL
Aromatic Rings	3.0
Heavy Atoms	24.0

Assay Description	Organism	Bioactivity
Phytotoxicity against two-leaf stage Oryza sativa cv. Nihonbare (rice) planted 1 cm depth measured after 20 to 25 weeks	Oryza sativa	2.5 g/acre
Phytotoxicity against two-leaf stage Oryza sativa cv. Nihonbare (rice) planted 3 cm depth measured after 20 to 25 weeks	Oryza sativa	20.0 g/acre
Herbicide activity against Sagittaria pygmaea under greenhouse condition compound treated at 0.5 leaf-stage measured after 14 to 20 days	Sagittaria pygmaea	10.0 g/acre
Herbicide activity against Schoenoplectiella juncoides under greenhouse condition compound treated at emergence-stage measured after 14 to 20 days	Schoenoplectiella juncoides	5.0 g/acre
Herbicide activity against Echinochloa oryzicola under greenhouse condition compound treated at 2 leaf-stage measured after 14 to 20 days	Echinochloa oryzicola	5.0 g/acre
Pre-emergence herbicide activity against Echinochloa oryzicola under greenhouse condition measured after 14 to 20 days	Echinochloa oryzicola	0.625 g/acre

Cross References

Resources	Reference
ChEMBL	CHEMBL2289087
PubChem	76334740

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).